Indivior shares give up gains ahead of move to the US
Opioid-use disorder treatment specialist Indivior (INDV) shot out the blocks in the early part of 2024 driven by stronger than expected full-year profit, (22 February) a strong outlook and excitement over its proposed US Nasdaq...
13 June 2024